Application no. and date | 15714951.9 (espacenet) (Federated) (European Patent Register), 20150318 | Patent/reg. no. and date | DK/EP 3126361, 20191106 | Publication date | 20170208 | Priority no. and date | US 201461973436 P, 20140401 | EP pub. no. and date |
EP 3126361 20170208 | Effective date | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | Applicant ref. no. | P81904708DK00E | Inventor | VERHOEST, Patrick Robert, 23 Calvin Road
Newton, Massachusetts 02460, US, AM ENDE, Christopher William, 32 Hunting Ridge Drive
Mystic, Connecticut 06355, US, JOHNSON, Douglas Scott, 85 Adin Drive
Concord, Massachusetts 01742, US, KAUFFMAN, Gregory Wayne, 30 Boulder Way
East Greenwich, Rhode Island 02818, US, PETTERSSON, Martin Youngjin, 3 Gilson Road
Littleton, Massachusetts 01460, US, HUMPHREY, John Michael, 110 Haley Road
Mystic, Connecticut 06355, US, RANKIC, Danica Antonia, 304 Main Street Apt. 1A
Niantic, Connecticut 06357, US, STEPAN, Antonia Friederike, 1110 Beacon Street Apt. 2B
Brookline, Massachusetts 02446, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/4985 (2006.01) , A61P 25/28 (2006.01) , C07D 471/04 (2006.01) | Title | CHROMEN OG 1,1A,2,7B-TETRAHYDROCYCLOPROPA[C]CHROMEN- PYRIDOPYRAZINDIONER SOM GAMMA-SEKRETASE-MODULATORER | Int. application no. | IB2015051988 | Int. publication no. | WO2015150957 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|